TBI Evaluation and Management (TEaM)
Launched by EMORY UNIVERSITY · Oct 1, 2020
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
The TBI Evaluation and Management (TEaM) trial is studying how a team of healthcare professionals can work together to help children who have experienced a mild traumatic brain injury (mTBI). The goal is to improve how these injuries are diagnosed and managed, ensuring that doctors, families, and schools can make better decisions during the recovery process. This study is currently looking for participants, including children aged 5 to 18 who have been seen by a doctor within 72 hours of their injury and were discharged home afterward.
To be eligible for the trial, children should have a diagnosis of mTBI or show signs of it as assessed by a healthcare professional. However, there are some exclusions, such as if the child has a severe developmental delay or has had a recent severe brain injury. Participants in the study can expect to receive comprehensive care and support throughout their recovery, and their experiences will help improve future care for other children with similar injuries. If you're considering participation, it's important to know that consent will be required, and families will be involved in the process.
Gender
ALL
Eligibility criteria
- • PROVIDER INCLUSION CRITERIA
- • Actively practicing physician or APP in the CHOA System
- • Primary practice in either ED, UC, and/or PCP
- • PROVIDER EXCLUSION CRITERIA
- • Inability or unwillingness to provide written/electronic informed consent
- • Unable to fulfill study training / education requirements
- • CHILD INCLUSION CRITERIA - RETROSPECTIVE
- • School age (5-18 yoa)
- • Evaluated in ED / UC / PCP within 72 hours of injury
- • Discharged home from ED / UC / PCP (e.g., not admitted to hospital)
- • CHILD EXCLUSION CRITERIA - RETROSPECTIVE
- • Non-English speaking
- • Known severe developmental delay or known severe psychiatric history
- • Known prior severe brain injury
- • Known mTBI within past 3 months
- • First mTBI visit outside of CHOA network
- • CHILD INCLUSION CRITERIA - PROSPECTIVE
- * Meets above inclusion for retrospective portion plus:
- * mTBI likely present as defined by:
- • Positive diagnosis by clinician or mTBI OR
- • Positive triage screen plus positive symptom checklist
- • CHILD EXCLUSION CRITERIA - PROSPECTIVE
- * Does not meet above exclusion for retrospective portion plus:
- • Requests to Opt-Out via e-mail or first phone contact
- • Inability or unwillingness to provide verbal informed telephone consent/assent
About Emory University
Emory University, a leading research institution located in Atlanta, Georgia, is dedicated to advancing medical knowledge and improving patient care through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration, Emory harnesses the expertise of its renowned faculty and state-of-the-art facilities to conduct cutting-edge research across various fields, including oncology, neurology, and infectious diseases. The university's commitment to ethical research practices and patient safety ensures that all clinical trials are designed to generate valuable data that can lead to significant therapeutic advancements. By fostering partnerships with local hospitals and community organizations, Emory strives to translate research findings into real-world applications, ultimately enhancing health outcomes for diverse populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Atlanta, Georgia, United States
Atlanta, Georgia, United States
Atlanta, Georgia, United States
Patients applied
Trial Officials
David Wright, MD
Principal Investigator
Emory University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials